Abstract
There is substantial indirect evidence that oxidative stress occurs during the course of diabetes mellitus. This is based upon reports of elevation in lipid peroxides (i.e., malondialdehyde) in plasma of experimental diabetic rodents (1–3) and in plasma of human type I and type II diabetes mellitus (2,4-7). More recently, F2-isoprostanes, nonenzymatic peroxidation products, were shown to be increased in plasma of diabetic patients (8). In addition to elevated concentrations of lipid peroxides, oxidation of LDL, increased formation of glycated proteins, and elevated plasma concentrations of ceruloplasmin (9,10) have supported a role for increased oxidative stress in diabetic patients.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Matkovics B, Varga SI, Szabó L, Witas H. The effect of diabetes on the activities of the peroxide metabolism enzymes. Horm Metab Res. 1982;14:77.
Dohi T, Kawamura K, Morita K, Okamoto H, Tsujimoto A. Alterations of the plasma selenium concentrations and the activities of tissue peroxide metabolism enzymes in streptozotocin-induced diabetic rats. Horm Metab Res. 1988;20:671.
Higuchi Y. Lipid peroxides and (-tocopherol in rat streptozotocin-induced diabetes mellitus. Acta Med Okayama. 1982;3:165.
Sato Y, Hotta N, Sakamoto N, Matsuoka S, Ohishi N, Yagi K. Lipid peroxide level in plasma of diabetic patients. Biochem Med. 1979;21:104.
Gallou G, Ruelland A, Legras B, Maugendre D, Allannic H, Cloarec L. Plasma malondialdehyde in type 1 and type 2 diabetic patients. Clin Chim Acta. 1993;214:227.
Gallou G, Ruelland A, Campion L, Maugendre D, Le Moullec N, Legras B, Allannic H, Cloarec L. Increase in thiobarbituric acid-reactive substances and vascular complications in type 2 diabetes mellitus. Diabete & Metabolisme (Paris). 1994;20:258.
Griesmacher A, Kindhauser M, Andert SE, Schreiner W, Toma C, Knoebl P, Pietschmann P, Prager R, Schnack C, Schernthaner G, Mueller MM. Enhanced serum levels of thiobarbituric-acid-reactive substances in diabetes mellitus. Am J Med. 1995;98:469.
Gopaul NK, Änggård, Mallet AI, Betteridge DJ, Wolff SP, Nourooz-Zadeh J. Plasma 8-epi-PGF2 levels are elevated in individuals with non-insulin dependent diabetes mellitus. FEBS Lett. 1995;368:225.
Cunningham J, Leffell M, Mearkle P, Harmatz P. Elevated plasma ceruloplasmin in insulindependent diabetes mellitus: evidence for increased oxidative stress as a variable complication. Metabolism. 1995;44:996.
MacRury SM, Gordon D, Wilson R, Bradley H, Gemmell CG, Paterson JR, Rumley AG, MacCuish AC. A comparison of different methods of assessing free radical activity in type 2 diabetes and peripheral vascular disease. Diab Med. 1992;10:331.
Tribe RM, Poston L. Oxidative stress and lipids in diabetes: a role in endothelium vasodilator dysfunction? Vasc Med. 1996;1:195.
Giugliano D, Ceriello A, Paolisso G. Oxidative stress and diabetic vascular complications. Diabetes Care. 1996;19:257.
Kakkar R, Mantha SV, Kalra J, Prasad K. Time course study of oxidative stress in aorta and heart of diabetic rat. Clin Sci. 1997;91:441.
Wolff SP, Jiang ZY, Hunt JV. Protein glycation and oxidative stress in diabetes mellitus and ageing. Free Radical Biol Med. 1991;10:339.
Baynes JW: Role of oxidative stress in development of complications of diabetes. Diabetes. 1991; 40:405.
Williamson JR, Chang K, Frangos M, Hasan KS, Ido Y, Kawamura T, Nyengaard JR, Van Den Enden M, Kilo C, Tilton RG. Hyperglycemic pseudohypoxia and diabetic complications. Diabetes. 1993;42:801.
Chappey O, Dosquet C, Wautier M-P, Wautier J-L. Advanced glycation end products, oxidant stress and vascular lesions. Eur J Clin Invest. 1997;27:97.
Pieper GM, Gross GJ. “Endothelial Dysfunction in Diabetes” In Cardiovascular Significance of Endothelium-Derived Vasoactive Factors, GM Rubanyi, ed. Mount Kisco, NY: Futura Publishing Co., Inc., 1991:223.
Kamata N, Miyata N, Abiru T, Kasuya Y. Functional changes in vascular smooth muscle and endothelium of arteries during diabetes mellitus. Life Sci. 1992;50:1379.
Cohen RA. Dysfunction of vascular endothelium in diabetes mellitus. Circulation. 1993;87(suppl. V):V-67.
Poston L, Taylor PD. Endothelium-mediated vascular function in insulin-dependent diabetes mellitus. Clin Sci. 1995;88:245.
Sobrevia L, Mann GE. Dysfunction of the endothelilal nitric oxide signalling pathway in diabetes and hyperglycaemia. Exp Physiol. 1997;82:423.
Pieper GM. Review of alterations in endothelial nitric oxide production in diabetes: protective role of arginine on endothelial dysfunction. Hypertension. 1998;31:1047.
Langenstroer P, Pieper GM. Regulation of spontaneous EDRF release in diabetic rat aorta by oxygen free radicals. Am J Physiol. 1992;263 (Heart Circ Physiol 32).H257
Ohishi K, Carmines PK. Superoxide dismutase restores the influence of nitric oxide on renal arterioles in diabetes mellitus. J Am Soc Nephrol. 1995;5:1559.
Hattori Y, Kawasakie H, Abe K, Kanno M. Superoxide dismutase recovers altered endothelium-dependent relaxation in diabetic rat aorta. Am J Physiol. 1991;261(Heart Circ Physiol 30):H1086.
Pieper GM, Mei DA, Langenstroer P, O’Rourke ST. Bioassay of endothelium-derived relaxing factor in diabetic rat aorta. Am J Physiol. 1992:263 (Heart Circ Physiol 32):H676.
Tesfamariam B, Cohen RA. Free radicals mediate endothelial cell dysfunction caused by elevated glucose. Am J Physiol. 1992;263 (Heart Circ Physiol 32):H321.
Diederich D, Skopec J, Diederich A, Dai F-X. Endothelial dysfunction in mesenteric resistance arteries of diabetic rats: role of free radicals. Am J Physiol. 1994;266 (Heart Circ Physiol 35):H1153.
Mayhan WG. Superoxide dismutase partially restores impaired dilatation of the basilar artery during diabetes mellitus. Brain Res. 1997;760:204.
Rösen P, Ballhausen T, Bloch W, Addicks K. Endothelial relaxation is disturbed by oxidative stress in the diabetic rat heart: influence of tocopherol as antioxidant. Diabetologia. 1995;38:1157.
Kamata K, Kobayashi T. Changes in Superoxide dismutase mRNA expression by streptozotocin-induced diabetes. Br J Pharmacol. 1996;119:583.
Pieper GM, Moore-Hilton G, Roza AM. Evaluation of the mechanism of endothelial dysfunction in the genetically-diabetic BB rat. Life Sci. 1996;58:147.
Dai F-X, Diederich A, Skopec J, Diederich D. Diabetes-induced endothelial dysfunction in streptozotocin-treated rats: role of Prostaglandin endoperoxides and free radicals. J Am Soc Nephrol. 1993;4:1327.
Heygate KM, Lawrence IG, Bennett MA, Thurston H. Impaired endothelium-dependent relaxation in isolated resistance arteries of spontaneously diabetic rats. Br J Pharmacol. 1995:116:3251.
Matsunaga T, Okumura K, Ishizaka H, Tsunoda R, Tayama S, Tabuchi T, Yasue H. Impairment of coronary blood flow regulation by endothelium-derived nitric oxide in dogs with alloxaninduced diabetes. J Cardiovasc Pharmacol. 1996;28:60.
Pieper GM, Langenstroer P, Siebeneich W. Diabetic-induced endothelial dysfunction in rat aorta: role of hydroxyl radicals. Cardiovasc Res. 1997;34:145.
Ammar RF Jr, Gutterman DD, Dellsperger KC. Topically applied Superoxide dismutase and catalase normalize coronary arteriolar responses to acetylcholine in diabetes mellitus in vivo. Circulation. 1994;90:1–57 (abstract).
Chang KC, Chung SY, Chong WS, Suh JS, Kim SH, Noh HK, Seong BW, Ko HJ, Chun KW. Possible Superoxide radical-induced alteration of vascular reactivity in aortas from streptozotocin-treated rats. J Pharmacol Exp Thera. 1993;266:992.
Pieper GM. Oxidative stress in diabetic blood vessels. FASEB J 1995;9:A891 (abstract).
Ohkuwa T, Sato Y, Naoi M. Hydroxyl radical formation in diabetic rats induced by strepotozotocin. Life Sci. 1995;56:1789.
Ghiselli A, Laurenti O, De Mattia G, Maiani G, Ferro-Luzzi A. Salicylate hydroxylation as an early marker of in vivo oxidative stress in diabetic patients. Free Radical Biol Med. 1992;13:621.
Gryglewski RJ, Palmer RMJ, Moncada S. Superoxide anion is involved in the breakdown of endothelium-derived relaxing factor. Nature. 1986;320:454.
Nitenberg A, Paycha F, Ledoux S, Sachs R, Attali J-R, Valensi P. Coronary artery responses to physiological stimluli are improved by deferoxamine but not by L-arginine in non-insulindependent diabetic patients with angiographically normal coronary arteries and no other risk factors. Circulation. 1998;97:736.
Mooradian AD. The antioxidant potential of cerebral microvessels in experimental diabetes mellitus. Brain Res. 1995;671:164.
Crouch R, Kimsey G, Priest DG, Sarda A, Buse MG: Effect of streptozotocin on erythrocyte and retinal Superoxide dismutase. Diabetelogia. 1978; 15:53.
Pieper GM, Jordan M, Dondlinger LA, Adams MB, Roza AM. Peroxidative stress in diabetic blood vessels: reversal by pancreatic islet transplantation. Diabetes. 1995;44:884.
Armstrong D, Al-Awadi F. Lipid peroxidation and retinopathy in streptozotocin-induced diabetes. Free Radical Biol Med. 1991;11:433.
Low PA, Nickander KK. Oxygen free radical effects in sciatic nerve in experimental diabetes. Diabetes. 1991;40:873.
Tatsuki R, Satoh K, Yamamoto A, Hoshi K, Ichihara K. Lipid peroxidation in the pancreas and other organs in streptozotocin diabetic rats. Jap J Pharmacol. 1997;75:267.
Tagami S, Kondo T, Yoshida K, Hirokawa J, Ohtsuka Y, Kawakami Y. Effect of insulin on impaired antioxidant activities in aortic endothelial cells from diabetic rabbits. Metabolism. 1992;41:1053.
Bucala R, Tracey KJ, Cerami A. Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes. J Clin Invest. 1991;87:432.
Rodriguez-Mafias L, Arribas S, Girón C, Villamor J, Sánchez-Ferrer CF, Marín J. Interference of glycosylated human hemoglobin with endothelium-dependent responses. Circulation. 1993;88[part l]:2111.
Angulo J, Sánchez-Ferrer CF, Peiró C, Marin J, Rodriguez-Mañas L. Impairment of endothelium-dependent relaxation by increasing percentages of glycosylated human hemoglobin: possible mechanisms involved. Hypertension. 1996;28:583.
Oltman CL, Gutterman DD, Scott EC, Bocker JM, Dellsperger KC. Effects of glycosylated hemoglobin on vascular responses in vitro. Cardiovasc Res. 1997;34:179.
Ellis EA, Grant MB, Murray FT, Wachowski MB, Guberski DL, Kubilis PS, Lutty GA. Increased NADH oxidase activity in the retina of the BBZ/Wor diabetic rat. Free Radical Biol Med. 1998;24:111.
Mohazzab-H KM, Kaminski PM, Wolin MS. NADH oxidoreductase is a major source of Superoxide anion in bovine coronary artery endothelium. Am J Physiol. 1994;266 (Heart Circ Physiol 35):H2568.
Jones SA, O’Donnell VB, Wood JD, Broughton JP, Hughes EJ, Jones OTG. Expression of phagocyte NADPH oxidase components in human endothelial cells. Am J Physiol. 1996;271 (Heart Circ Physiol 40):H1626.
Ushio-Fukai M, Zafari AM, Fukui T, Ishizaka N, Griendling KK. P22phox is a critical component of the superoxide-generating NADH/NADPH oxidase system and regulates angiotensin II-induced hypertrophy in vascular smooth muscle cells. J Biol Chemi. 1996;271:23317.
Pagano PJ, Clark JK, Cifuentes-Pagano ME, Clark SM, Callis GM, Quinn MT. Localization of a constitutively active, phagocyte-like NADPH oxidase in rabbit aortic adventitia: enhancement by angiotensin II. Proc Natl Acad Sci USA. 1997;94:14483.
Quian M, Brunk UT, Pieper GM, Eaton JW. Diabetic peripheral neuropathy: a possible involvement of iron bound to glycated basement membrane proteins. Ped Res. 1998;43:83A (abstact).
Heinzel B, John M, Klatt P, Böhme E, Mayer B. Ca2+/calmodulin-dependent formation of hydrogen peroxide by brain nitric oxide synthase. Biochem J. 1992;281:627.
Rösen P, Ballhausen T, Stockklauser K. Impairment of endothelium dependent relaxation in the diabetic rat heart: mechanisms and implications. Diabetes Res Clin Pract. 1996;31(suppl.):S143.
Pieper GM, Dondlinger LA. Plasma and vascular tissue arginine are decreased in diabetes: acute arginine supplementation restores endothelium-dependent relaxation by augmenting cGMP production. J Pharmacol Exp Thera. 1997;283:684.
Hamon CG, Cutler P, Blair JA. Tetrahydrobiopterin metabolism in the streptozotocin induced diabetic state in rats. Clin Chim Acta. 1989;181:249.
Öztürk Y, Aydin S, Altan VM, Yildizoglu-Ari N, Özçelikay AT. Effect of short and long term streptozotocin diabetes on smooth muscle calmodulin levels in the rat. Cell Calcium. 1994;16:81.
Pieper GM. Acute amelioration of diabetic endothelial dysfunction with a derivative of the nitric oxide synthase cofactor, tetrahydrobiopterin. J Cardiovasc Pharmacol. 1997;29:8.
Pieper GM, Peltier BA. Amelioration by L-arginine of a dysfunctional arginine/nitric oxide pathway in diabetic endothelium. J Cardiovasc Pharmacol. 1995;25:397.
Pieper GM, Jordan M, Adams MB, Roza AM. Syngeneic pancreatic islet transplantation reverses endothelial dysfunction in experimental diabetes. Diabetes. 1995;44:1106.
Pieper GM, Siebeneich W, Moore-Hilton G, Roza AM. Reversal by L-arginine of a dysfunctional arginine/nitric oxide pathway in the endothelium of the genetic diabetic BB rat. Diabetologia. 1997;40:910.
Pieper GM, Siebeneich W, Dondlinger LA. Short-term oral administration of L-arginine reverses defective endothelium-dependent relaxation and cGMP generation in diabetes. Eur J Pharmacol. 1996;317:317.
Böger RH, Bode-Böger SM, Brandes RP, Phivthong-ngam L, Böhme M, Nafe R, Mügge A, Frölich JC. Dietary L-arginine redues the progression of atherosclerosis in cholesterol-fed rabbits: comparison with lovastatin. Circulation. 1997;96:1282.
Taylor PD, Poston L. The effect of hyperglycaemia on function of rat isolated mesenteric resistance artery. Br J Pharmacol. 1994;113:801.
Félétou M, Rasetti C, Duhault J. Magnesium modulates endothelial dysfunction produced by elevated glucose incubation. J Cardiovasc Pharmacol. 1994;24:470.
Dorigo P, Fraccarollo D, Santostasi G, Maragno I. Impairment of endothelium-dependent but not endothelium-independent dilatation in guinea pig aorta rings incubated in the presence of elevated glucose. Br J Pharmacol. 1997;121:972.
Bohlen HG, Lash JM. Topical hyperglycemia rapidly suppresses EDRF-mediated vasodilation of normal rat arterioles. Am J Physiol. 1993, 265(Heart Circ Physiol 34):H219.
Mayhan WG, Patel KP. Acute effects of glucose on reactivity of cerebral microcirculation: role of activation of protein kinase C. Am J Physiol. 1995;269(Heart Circ Physiol 38):H1297.
Houben AJHM, Schaper NC, DeHaan HA, Huvers FC, Slaaf DW, DeLeeuw PW, Nieuwenhuijzen-Kruseman AC. Local 24-h hyperglycemia does not affect endotheliumdependent or-independent vasoreactivity in humans. Am J Physiol. 1996;270 (Heart Circ Physiol 39):H2014.
Akbari C, Saouaf R, Barnhill D, Newman P, Logerfo F. Endothelium-dependent vasodilatation is impaired during acute hyperglycemia. Diabetes. 1997;46 (supp. 1): 114A (abstract).
Lee T-S, Saltsman KA, Ohashi H, King GL. Activation of protein kinase C by elevation of glucose concentration: proposal for a mechanism in the development of diabetic vascular complications. Proc Natl Acad Sci USA. 1989;86:5141.
Weisbrod RM, Brown ML, Cohen RA. Effect of elevated glucose on cyclic GMP and eicosanoids produced by porcine aortic endothelium. Arterterioscler Thromb. 1993;13:915.
Pieper GM, Dondlinger L. Glucose elevations alter bradykinin-stimulated intracellular calcium accumulation in cultured endothelial cells. Cardiovasc Res. 1997;34:169.
Magill SB, Danaberg J. “Effects of hyperglycemia on vascular endothelium nitric oxide metabolism” In Contemporary Endocrinology: Endocrinology of the Vasculature, JR Sowers, ed,. Totowa, NJ: Humana Press Inc.; 1996:145.
Salameh A, Dhein S. Influence of chronic exposure to high concentrations of D-glucose and long-term ®-blocker treatment on intracellular calcium concentrations of porcine aortic endothelial cells. Diabetes. 1998;47:407.
Pieper GM, Dondlinger LA. The antioxidant, Pyrrolidine dithiocarbamate, prevents defective bradykinin-stimulated calcium accumulation and nitric oxide activity following exposure of endothelial cells to elevated glucose concentration. Diabetologia. 1998;41:806.
Kimura C, Oike M, Kashiwagi S, Ito Y. Effects of glucose overload on histamine H2 receptormediated Ca2+ mobilization in bovine cerebral endothelial cells. Diabetes. 1998;47:104.
Mazière C, Auclari M, Rose-Robert F, Leflon P, Mezière JC. Glucose-enriched medium enhances cell-mediated low density lipoprotein peroxidation. Febs Lett. 1995;363:277.
Graier WF, Simecek S, Hoebel BG, Wascher TC, Dittrich P, Kostner GM. Antioxidants prevent high D-glucose-enhanced endothelial Ca2+/cGMP response by scavenging Superoxide anions. Eur J Pharmacol. 1997;322:113.
Cosentino F, Hishikawa K, Katusic ZS, Lüscher TF. High glucose increases nitric oxide synthase expression and Superoxide anion generation in human aortic endothelial cells. Circulation. 1997;96:25.
Pellligrino DA, Koenig HM, Wang Q, Albrecht RF. Protein kinase C suppresses receptormediated pial arteriolar relaxation in the diabetic rat. NeuroReport. 1994;5:417.
Ohara Y, Peterson TE, Zheng B, Kuo JF, Harrison DG. Lysophosphatidylcholine increases vascular Superoxide anion production via protein kinase C activation. Arterioscler Thromb. 1994;14:1007.
Ting HH, Timimi FK, Boles KS, Creager SJ, Ganz P, Creager MA. Vitamin C improves endothelium-dependent vasodilation in patients with non-insulin-dependent diabetes mellitus. J Clin Invest. 1996;97:22.
Timimi FK, Ting HH, Haley EA, Roddy M-A, Ganz P, Creager MA. Vitamin C improves endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus. J Am Coll Cardiol. 1998;31:552.
Keegan A, Walbank H, Cotter MA, Cameron NE. Chronic vitamin E treatment prevents defective endothelium-dependent relaxation in diabetic rat aorta. Diabetologia. 1995;38:1475.
Karasu Ç, Ozansoy G, Bozkurt O, Erdogan D, Ömeroglu S. Isoprenaline-induced endotheliumdependent and-independent relaxations of aorta in long-term STZ-diabetic rats: reversal effect of dietary vitamin E. Gen Pharmacol. 1997;29:561.
Archibald V, Cotter MA, Keegan A, Cameron NE. Contraction and relaxation of aortas from diabetic rats: effects of chronic anti-oxidant and aminoguanidine treatments. Naunyn-Schmiedeberg’s Arch Pharmacol. 1996;353:584.
Pieper GM, Siebeneich W: Oral administration of the antioxidant, N-acetylcysteine, abrogates diabetes-induced endothelial dysfunction. J Cardiovasc Pharmacol. 1998; 41:101.
Pieper GM, Siebeneich W, Roza AM, Jordan M, Adams MB. Chronic treatment in vivo with dimethylthiourea, a hydroxyl radical scavenger, prevents diabetes-induced endothelial dysfunction. J Cardiovasc Pharmacol. 1996;28:741.
Mayhan WG, Patel KK. Treatment with dimethylthiourea prevents impaired dilatation of the basilar artery during diabetes mellitus. Am J Physiol. 1998;214(Heart Circ Physiol. 43):H1895.
Pieper GM, Siebeneich W. Diabetes-induce endothelial dysfunction is prevented by long-term treatment with the modified iron chelator, hydroxyethyl starch conjugated-deferoxamine. J Cardiovasc Pharmacol. 1997;30:734.
Karasu Ç, Ozansoy G, Bozhurt D, Ömeroglu S. Antioxidant and triglyceride-lowering effect of vitamin E associated with the prevention of abnormalities in the reactivity and morphology of aorta from streptozotocin-diabetic rats. Metabolism. 1997;46:872.
Palmer AM, Gopaul N, Dhir S, Thomas CR, Poston L, Tribe RM. Endothelial dysfunction in streptozotocin-diabetic rats is not reversed by dietary probucol or simvastatin supplementation. Diabetologia. 1998;41:157.
Palmer AM, Thomas CR, Gopaul N, Dhir S, Änggård EE, Poston L, Tribe RM. Dietary antioxidant supplementation reduces lipid peroxidation but impairs vascular function in small mesenteric arteries of the streptozotocin-diabetic rat. Diabetologia. 1998;41:148.
Bertuglia S, Malandrino S, Colantuoni A. Effects of the natural flavonoid delphinidin on diabetic microangiopathy. Arzn-Forschung/Drug Res. 1995;45:481.
Cameron NE, Cotter MA, Archibald V, Dines KC, Maxfield EK. Anti-oxidant and pro-oxidant effects on nerve conduction velocity, endoneurial blood flow and oxygen tension in non-diabetic and streptozotocin-diabetic rats. Diabetologia. 1994;37:449.
Cameron NE, Cotter MA. Reversal of peripheral nerve conduction and perfusion deficits by the free radical scavenger, BM15.0639, in diabetic rats. Naunyn-Schmiedeberg’s Arch Pharmacol. 1995;352:685.
Cotter MA, Love A, Watt MJ, Cameron NE, Dines KC. Effects of natural free radical scavengers on peripheral nerve and neurovascular function in diabetic rats. Diabetologia. 1995;38:1285.
Cameron NE, Cotter MA. Neurovascular dysfunction in diabetic rats. Potential contribution of autoxidation and free radicals examined using transition metal chelating agents. J Clin Invest. 1995;96:1159.
Pieper GM, Jordan M, Roza AM: Chronic treatment with the 21-aminosteroid U74389F an inhibitor of lipid peroxidation, does not prevent diabetic endothelial dysfunction. Cardiovasc Drugs Therapy. 1997; 11:435.
Tilton RG, Chang K, Hasan KS, Smith SR, Petrash JM, Misko TP, Moore WM, Currie WG, Corbett JA, McDaniel ML, Williamson JR. Prevention of diabetic vascular dyfsunction by guanidines. Inhibition of nitric oxide synthase versus advanced glycation end-product formation. Diabetes. 1993;42:221.
Kumari K, Umar S, Bansal V, Sahib MK. Inhibition of diabetes-associated complications by nucleophilic compounds. Diabetes. 1991;1079.
Brownlee M, Vlassara H, Kooney A, Ulrich P, Cerami A. Aminoguanidine prevents diabetesinduced arterial wall protein cross-linking. Science. 1986;232:1629.
Picard S, Parthasrathy S, Fruebis J, Witztum JL. Aminoguanidine inhibits oxidative modification of low density lipoprotein protein and the subsequent increase in uptake by the macrophage scavenger receptor. Proc Natl Acad Sci USA. 1992;89:6876.
Philis-Tsimikas A, Parthasarathy S, Picard S, Palinski W, Witztum J: Aminoguanidine has both pro-oxidant and antioxidant activity toward LDL. Arterioscler Thromb Vasc Biol. 1994; 15:367.
Cameron NE, Cotter MA. Impaired contraction and relaxation in aorta from streptozotocindiabetic rats: role of polyol pathway. Diabetelogia. 1992;35:1011.
Tesfamariam B, Palacino JJ, Weisbrod RM, Cohen RA. Aldose reductase inhibition restores endothelial cell function in diabetic rabbit aorta. J Cardiovasc Pharmacol. 1993;21:205.
Otter DJ, Chess-Williams R: The effects of aldose reductase inhibition with ponalrestat on changes in vascular function in streptozotocin diabetic rats. Br J Pharmacol. 1994; 113:576.
Jian ZY, Zhou Q-L, Eaton JW, Koppenol WH, Hunt JV, Wolff SP. Spirohydantoin inhibitors of aldose reductase inhibit iron-and copper-catalyzed ascorbate oxidation in vitro. Biochem Pharmacol. 1991;42:1273.
Hunt JV, Dean RT, Wolff SP. Hydroxyl radical production and autoxidative glycosylation. Glucose autoxidation as the cause of protein damage in the experimental glycation model of diabetes mellitus and ageing. Biochem J. 1988;256:205.
Ceriello A, Giugliano D, Quatraro A, Donzella C, Cipalo G, Lefebvre PJ. Vitamin E reduction of protein glycosylation in diabetes. New prospect for prevention of diabetic complications. Diabetes Care. 1991;14:68.
Davies SJ, Gould BJ, Yudkin JS. Effect of vitamin C on glycosylation of proteins. Diabetes. 1992;41:167.
Shoff SM, Mares-Perlman JA, Cruickshanks KJ, Klein R, Klein BEK, Ritter LL. Glycosylated hemoglobin concentrations and vitamin E, vitamin C, and ®-carotene intake in diabetic and nondiabetic older aldults. Am J Clin Nutr. 1993;58:412.
Soulis T, Cooper ME, Sastra S, Thallas V, Panagiotopoulos S, Bjerrum OJ, Jerums G. Relative contributions of advanced glycation and nitric oxide synthase inhibition to aminoguanidinemediated renoprotection in diabetic rats. Diabetologia. 1997;40:1141.
Richardson M, Hadcock SJ, DeReske M, Cybulsky MI. Increase expression in vivo of VCAM-1 and E-selectin by the aortic endothelium of normolipemic and hyperlipemic diabetic rabbits. Arterioscler Thromb. 1994;14:760.
McLeod DS, Lefer DJ, Merges C, Lutty GA. Enhanced expression of intracellular adhesion molecule-1 and P-selectin in the diabetic human retina and choroid. Am J Pathol. 1995;147:642.
Schmidt AM, Crandall J, Hori O, Cao R, Lakatta E. Elevated plasma levels of vascular cell adhesion molecule-1 (VCAM-1) in diabetic patients with microalbuminuria: a marker of vascular dysfunction and progressive vascular disease. Br J Haematol. 1996;92:747.
Fasching P, Veitl M, Rohac M, Streli C, Schneider B, Waldhäusl W, Wagner OF. Elevated concentrations of circulating adhesion molecules and their association with microvascular complications in insulin-dependent diabetes mellitus. J Clin Invest. 1996;81:4313.
Jude EB, Abbott CA, Young MJ, Anderson SG, Douglas JT, Boulton AJM. The potential role of cell adhesion molecules in the pathogenesis of diabetic neuropathy. Diabetologia. 1998;41:330.
Baumgartner-Parzer SM, Wagner L, Pettermann M, Gessl A, Waldhäsl W. Modulation by high glucose of adhesion molecule expression in cultured endothelial cells. Diabetologia. 1995;38:1367.
Taki H, Kashiwagi A, Tanaka Y, Horiike K. Expression of intercellular adhesion molecules (ICAM-1) via an osmotic effect in human umbilical vein endothelial cells exposed to high glucose medium. Life Sci. 1996;58:1713.
Kim JA, Berliner JA, Natarajan RD, Nadler JL. Evidence that glucose increases monocyte binding to human aortic endothelial cells. Diabetes. 1994;43:1103.
Weber C, Erl W, Pietsch A, Sröbel M, Ziegler-Heitbrock HWL, Weber PC. Antioxidants inhibit monocyte adhesion by suppressing nuclear factor-κB moblilization and induction of vascular cell adhesion molecule-1 in endothelial cells stimulated to generate radicals. Arterioscler Thromb. 1994;14:1665.
Weber C, Erl W, Pietsch A, Weber PC. Aspirin inhibits nuclear factor-κB mobilization and monocyte adhesion in stimulated human endothelial cells. Circulation. 1995;91:1914.
Ferrans C, Millan MT, Csizmadia V, Cooper JT, Brostjan C, Bach FH, Winkler H. Inhibition of NF-κB by Pyrrolidine dithiocarbamate blocks endothelial cell activation. Biochem Biophys Res Comm. 1995;214:212.
Mauri N, Offerman Mk, Swerlick R, Kunsch C, Rosen CA, Ahmad M, Alexander RW, Medford RM. Vascular cell adhesion molecule-1 (VCAM-1) gene transcription and expression are regulated through an antioxidant-sensitive mechanism in vascular endothelial cells. J Clin Invest. 1993;92:1866.
Gerritsen ME, Carley WW, Ranges GE, Shen C-P, Phan SA, Ligon CF, Perry CA. Flavonoids inhibit cytokine-induced endothelial cell adhesion protein gene expression. Am J Pathol. 1995;147:278.
Pieper GM, ul-Haq R. Activation of nuclear factor-κB in cultured endothelial cells by increased glucose concentration: prevention by calphostin C. J Cardiovasc Pharmacol. 1997;30:528.
Schmidt AM, Hori O, Chen JX, Li JF, Crandall J, Zhang J, Cao R, Yan SD, Brett J, Stern D. Advanced glycation endproducts interacting with their endothelial recepter induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. A potential mechanism for the accelerated vasculopathy of diabetes. J Clin Invest. 1995;96:1395.
Bierhaus A, Chevion S, Chevion M, Hofmann M, Quehenberger P, Illmer T, Luther T, Berentshtein E, Tritscher H, Müller M, Wahl P, Ziegler R, Nawroth PP. Advanced glycation end produt-induced activation of NF-KB is suppressed by (-lipoic acid in cultured endothelial cells. Diabetes. 1997;46:1481.
Mazière C, Auclair M, Djavaheri-Mergny M, Packer L, Mazière J-C. Oxidized low density lipoprotein induces activation of the transcription factor NF-κB in fibroblasts, endothelial and smooth muscle cells. Biochem Mol Biol Int. 1996;39:1201.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Springer Science+Business Media New York
About this chapter
Cite this chapter
Pieper, G.M. (2000). Hyperglycemia and Diabetes — Induced Vascular Dysfunction: Role of Oxidative Stress. In: Keaney, J.F. (eds) Oxidative Stress and Vascular Disease. Developments in Cardiovascular Medicine, vol 224. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-4649-8_16
Download citation
DOI: https://doi.org/10.1007/978-1-4615-4649-8_16
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-7103-8
Online ISBN: 978-1-4615-4649-8
eBook Packages: Springer Book Archive